IP Library Granted Patent US 9,750,697
Granted Patent B2
US 9,750,697 · App. 14/234,944 · Granted Sep 5, 2017

Delivery of an active material

Inventors: Roghieh Saffie-Siebert (Down, GB); Nasrollah Torabi-Pour (Down, GB)
Assignee: SiSaf Limited
A61K9/1611A61K8/0279A61K8/25A61K8/671A61K9/0014A61K31/07A61Q19/00A61K2800/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,750,697
App. No.
14/234,944
Granted
Sep 5, 2017
Kind
B2
Abstract

A composition for use as a topical delivery system for an active material is provided, the composition comprising a plurality of skin cell removal particles and a plurality of active material molecules, at least some of the skin cell removal particles each carrying at least one active material molecule, wherein carrying of an active material molecule by a skin cell removal particle maintains activity of the active material molecule. A topical delivery system for an active material, and a method of topical delivery of an active material are also provided.

Claims (27)

1. A composition comprising a plurality of skin cell removal particles and a plurality of active material molecules,

wherein the skin removal particles comprise at least one elemental silicon particle,

wherein the elemental silicon particle has a jagged outer surface,

wherein at least some of the skin cell removal particles each carry at least one active material molecule, and

wherein carrying of at least one active material molecule by a skin cell removal particle stabilizes an activity of the at least one active material molecule.

2. The composition of claim 1 , wherein at least some of the skin cell removal particles comprise one or more pores, wherein at least one active material molecule is disposed in at least some of the pores.

3. The composition of claim 1 , wherein at least some of the skin cell removal particles comprise a hollow shell, wherein at least one active material molecule is disposed in at least some of the hollow shells.

4. The composition of claim 1 , wherein the at least one active material molecule is detachably fixed onto an external surface of a skin cell removal particle.

5. The composition of claim 1 , wherein the at least one active material molecule is detachably linked to a skin cell removal particle.

6. The composition of claim 1 , wherein the at least one active material molecule is carried by a delivery vehicle molecule, and wherein at least one delivery vehicle molecule is carried by a skin cell removal particle.

7. The composition of claim 6 , wherein the delivery vehicle is one or more delivery vehicles selected from the group consisting of lipid-based materials, polymer-based materials, liposomes, niosomes, polymers, dendrimers, emulsions, collagen, ceramides, cholesterol and cyclodextrin.

8. The composition of claim 1 , wherein the carrying of at least one active material molecule by a skin cell removal particle maintains one or more activities of the active material molecule selected from the group consisting of maintaining stability of the active material molecule, maintaining solubility of the active material molecule, improving solubility of the active material molecule, and increasing partitioning of the active material molecules.

9. The composition of claim 1 , wherein the active material molecule is one or more molecules selected from the group consisting of vitamins, moisturizing agents, anti-UV agents, anti-inflammatory agents, anti-oxidants, free radical scavengers, anti-seborrhoeic agents, keratolytic agents, refreshing agents, melanoregulators, liporegulators, anti-ageing agents, anti-bacterial agents, vascular protectors, anti-fungal agents, skin conditioners, immunomodulators, nutrients, essential oils, retinoids, anaesthetics, vaccines, antigens and anti-bodies.

10. A topical delivery system for an active material comprising a composition according to claim 1 .

11. A method for topical delivery of an active material comprising

applying a composition to a portion of skin, wherein the composition comprises a plurality of skin cell removal particles and a plurality of active material molecules,

wherein at least some of the skin cell removal particles each carry at least one active material molecule,

wherein carrying of at least one active material molecule by a skin cell removal particle maintains activity of the at least one active material molecule;

working the composition against the portion of skin to remove stratum corneum cells;

dissociating the active material molecules from the skin cell removal particles; and

delivering the active material molecules to sub-corneum skin layers.

12. The method of claim 11 , wherein working the composition against the skin removes substantially all stratum corneum cells of the skin portion providing a gap which allows the active material molecules to reach sub-corneum skin layers.

13. The method of claim 11 , wherein working the composition against the skin removes some layers of stratum corneum cells of the skin portion which allows the active material molecules to penetrate through remaining layers of stratum corneum cells of skin portion to sub-corneum skin layers.

14. The method of claim 11 , wherein working the composition against the skin to remove some layers of stratum corneum cells of the skin portion decreases the packing density of the remaining layers of stratum corneum cells enabling pores of the skin to increase in diameter and allowing the active material molecules to penetrate through the remaining layers of stratum corneum cells by transport thereof through the pores.

15. The method of claim 11 , wherein working the composition against the skin to remove some layers of stratum corneum cells of the skin portion decreases the packing density of the remaining layers of stratum corneum cells causing spacing of the cells and allowing the active material molecules to penetrate through the remaining layers of stratum corneum cells by penetration between the cells.

16. The composition of claim 1 , wherein the skin cell removal particles further comprises one or more particles selected from the group consisting of porous silicon, porous crystal, porous germanium, porous diamond, porous gold, porous ceramic, and porous boron.

17. The composition of claim 1 , wherein the skin cell removal particles comprise about 0.01 to 50 wt % of the composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2017
From: SAFFIE-SIEBERT, ROGHEIH; TORABI-POUR, NASROLLAH
To: SISAF LIMITED
Reel/Frame 043145/0852 →
Priority Claims (1)
GB 1112950.9 · Jul 27, 2011 · national
Continuity (1)
Related Publication 20140308353A1 · Oct 16, 2014